360 related articles for article (PubMed ID: 20302959)
1. Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Le RQ; Bevans M; Savani BN; Mitchell SA; Stringaris K; Koklanaris E; Barrett AJ
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1162-70. PubMed ID: 20302959
[TBL] [Abstract][Full Text] [Related]
2. Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.
Bevans MF; Mitchell SA; Barrett JA; Bishop MR; Childs R; Fowler D; Krumlauf M; Prince P; Shelburne N; Wehrlen L; Yang L
Biol Blood Marrow Transplant; 2014 Mar; 20(3):387-95. PubMed ID: 24355521
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported outcomes in survivors of childhood hematologic malignancies with hematopoietic stem cell transplant.
Yen HJ; Eissa HM; Bhatt NS; Huang S; Ehrhardt MJ; Bhakta N; Ness KK; Krull KR; Srivastava DK; Robison LL; Hudson MM; Huang IC
Blood; 2020 May; 135(21):1847-1858. PubMed ID: 32243495
[TBL] [Abstract][Full Text] [Related]
4. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
Gifford G; Sim J; Horne A; Ma D
Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
[TBL] [Abstract][Full Text] [Related]
5. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.
Diep PP; Rueegg CS; Burman MM; Brinch L; Bø K; Fosså K; Landrø L; Loge JH; Lund MB; Massey RJ; Myrdal OH; Pathak M; Rimstad L; Tanem KE; Tjønnfjord GE; Aaløkken TM; Ruud E
J Adolesc Young Adult Oncol; 2023 Feb; 12(1):66-75. PubMed ID: 35544321
[No Abstract] [Full Text] [Related]
6. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
7. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.
Rovó A; Daikeler T; Halter J; Heim D; Tsakiris DA; Stern M; Waltimo T; Studt JD; Tyndall A; Gratwohl A; Tichelli A
Haematologica; 2011 Jan; 96(1):150-5. PubMed ID: 20851864
[TBL] [Abstract][Full Text] [Related]
8. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies.
Luo Y; Zeng HQ; Shen Y; Zhang P; Lou SF; Chen L; Deng JC
Leuk Res; 2016 Sep; 48():6-10. PubMed ID: 27416327
[TBL] [Abstract][Full Text] [Related]
11. Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
Georges GE; Maris M; Sandmaier BM; Malone DG; Feinstein L; Niederweiser D; Shizuru JA; McSweeney PA; Chauncey TR; Agura E; Little MT; Sahebi F; Hegenbart U; Pulsipher MA; Bruno B; Forman S; Woolfrey AE; Radich JP; Blume KG; Storb R
Int J Hematol; 2002 Aug; 76 Suppl 1():184-9. PubMed ID: 12430851
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell Transplantation.
Newcomb R; Johnson PC; Cronin K; Choe JJ; Holmbeck K; Nabily A; Lark P; Rabideau DJ; DeFilipp Z; Chen YB; El-Jawahri A
Transplant Cell Ther; 2023 Jun; 29(6):387.e1-387.e7. PubMed ID: 36958693
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation.
Inaba H; Yang J; Kaste SC; Hartford CM; Motosue MS; Chemaitilly W; Triplett BM; Shook DR; Pui CH; Leung W
J Clin Oncol; 2012 Nov; 30(32):3991-7. PubMed ID: 23032628
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey.
McErlean G; Tapp C; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I
BMC Psychol; 2023 Aug; 11(1):235. PubMed ID: 37587508
[TBL] [Abstract][Full Text] [Related]
16. Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study.
Brice L; McErlean G; Donovan C; Tapp C; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I
Eur J Oncol Nurs; 2020 Dec; 49():101845. PubMed ID: 33128994
[TBL] [Abstract][Full Text] [Related]
17. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.
Bevans MF; Mitchell SA; Barrett AJ; Bishop M; Childs R; Fowler D; Krumlauf M; Prince P; Shelburne N; Wehrlen L
Health Qual Life Outcomes; 2011 Apr; 9():24. PubMed ID: 21496339
[TBL] [Abstract][Full Text] [Related]
18. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
19. Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies.
Moneib H; Hafez H; Abdalla A; Hassanain O; Lehmann L; Haddad AE
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e221-e227. PubMed ID: 30846344
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation.
Inaba H; Yang J; Pan J; Stokes DC; Krasin MJ; Srinivasan A; Hartford CM; Pui CH; Leung W
Cancer; 2010 Apr; 116(8):2020-30. PubMed ID: 20186702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
